Clinical Trial: A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614191) titled 'A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases' on May 13.

Brief Summary: This study is an open-label, single-arm, dose-escalation and dose-expansion clinical trial designed to evaluate the safety, efficacy and cellular pharmacokinetics of GT801 injection in patients with moderate to severe refractory autoimmune diseases.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Refractory Autoimmune Diseases

Intervention: BIOLOGICAL: GT801 Injection

GT801 Injection

Recruitment Status: NOT_YET_RECRUITING ...